Therapeutic Use and Other Reasons to Consume Cannabidiol: Insight from the French and Italian Contexts
Author:
Affiliation:
1. Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale, ISSPAM, Marseille, France
Funder
no funding
Publisher
Informa UK Limited
Subject
General Psychology,Medicine (miscellaneous)
Link
https://www.tandfonline.com/doi/pdf/10.1080/02791072.2023.2285843
Reference55 articles.
1. Recreational Cannabidiol: Awareness, Prevalence of use, and Associated Factors in a Representative Sample of the German Population
2. Article R5132-86-1—Code de la santé publique. 2022. https://www.legifrance.gouv.fr/codes/article_lc/LEGIARTI000045186082/2022-03-01.
3. Exclusive Therapeutic Use of Cannabis in a Large Sample of Daily Cannabis Users in France: A Cross-Sectional Survey
4. The emerging role of cannabidiol ( CBD ) products; a survey exploring the public's use and perceptions of CBD
5. Cannabidiol: pharmacology and therapeutic targets
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. What can we learn from low-THC cannabis growers in Europe? A comparative transnational study of small-scale cannabis growers from Italy and Switzerland;International Journal of Drug Policy;2024-06
2. Cannabidiol use in France in 2022: Results from a nationwide representative sample of adults;Drug and Alcohol Review;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3